loe 908 has been researched along with Age-Related Memory Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bareyre, FM; Brown, AL; Cheney, JA; Ensinger, HA; Leusch, A; Raghupathi, R; Russ, AB; Saatman, KE; Weisser, JD | 1 |
1 other study(ies) available for loe 908 and Age-Related Memory Disorders
Article | Year |
---|---|
The novel compound LOE 908 attenuates acute neuromotor dysfunction but not cognitive impairment or cortical tissue loss following traumatic brain injury in rats.
Topics: Acetamides; Animals; Brain Injuries; Catheterization; Cerebral Cortex; Cognition Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Isoquinolines; Male; Memory Disorders; Motor Skills Disorders; Neurologic Examination; Rats; Rats, Sprague-Dawley; Time Factors; Wounds, Nonpenetrating | 2000 |